tiprankstipranks
Stryker Corporation (SYK)
NYSE:SYK

Stryker Stock Forecast & Price Target

1,578 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Buy
17Ratings
10 Buy
7 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Stryker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SYK Stock Price Prediction

Average Price Target

$234.50
▲(15.78% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $234.50 with a high forecast of $260.00 and a low forecast of $205.00. The average price target represents a 15.78% change from the last price of $202.54.
Highest Price Target$260.00Average Price Target$234.50Lowest Price Target$205.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Evercore ISI
$245.00
Buy
20.96%
Upside
Reiterated
Stryker (SYK) PT Lowered to $245 at Evercore ISIEvercore ISI analyst Vijay Kumar lowered the price target on Stryker (NYSE: SYK) to $245.00 (from $250.00) while maintaining a Outperform rating.
Deutsche Bank
$205.00
Hold
1.21%
Upside
Reiterated
Deutsche Bank Sticks to Its Hold Rating for Stryker (SYK)
Cowen & Co.
$223.00
Buy
10.10%
Upside
Reiterated
Cowen Co. Maintains Outperform on Stryker, Lowers Price Target to $223
Stifel Nicolaus
$245.00
Buy
20.96%
Upside
Reiterated
Stryker price target lowered to $245 from $285 at StifelStryker price target lowered to $245 from $285 at Stifel
Morgan Stanley
$220.00
Hold
8.62%
Upside
Reiterated
Analysts Have Conflicting Sentiments on These Healthcare Companies: Exelixis (NASDAQ: EXEL), Seagen (NASDAQ: SGEN) and Stryker (NYSE: SYK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SYK Stock Forecast FAQ

What is SYK’s average 12-month price target, according to analysts?
Based on analyst ratings, Stryker’s 12-month average price target is $234.50.
    What is SYK’s upside potential, based on the analysts’ average price target?
    Stryker has 15.78% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SYK a Buy, Sell or Hold?
          Stryker has a conensus rating of Moderate Buy which is based on 10 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Stryker’s price target?
            The average price target for Stryker is $234.50. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $260.00 ,the lowest forecast is $205.00. The average price target represents 15.78% Increase from the current price of $202.54.
              What do analysts say about Stryker?
              Stryker’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis